Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Molecular Biology|April 1, 2006
A rearranging ligand enables allosteric control of catalytic activity in copper-containing nitrite reductaseHein J Wijma, Iain Macpherson, Maxime Alexandre, et al.
Plos Genetics|March 29, 2014
FAK acts as a suppressor of RTK-MAP kinase signalling in Drosophila melanogaster epithelia and human cancer cellsJuan Pablo Macagno, Jesica Diaz Vera, Yachuan Yu, et al.
Journal of the American Chemical Society|January 18, 2007
Effect of the methionine ligand on the reorganization energy of the type-1 copper site of nitrite reductaseHein J Wijma, Iain MacPherson, Ole Farver, et al.
Journal of Cell Science|January 8, 2017
A proteomic approach to identify endosomal cargoes controlling cancer invasivenessJesica Diaz-Vera, Sarah Palmer, Juan Ramon Hernandez-Fernaud, et al.
The Lancet. Gastroenterology & Hepatology|May 7, 2022
Community pathways for the early detection and risk stratification of chronic liver disease: a narrative systematic reviewKushala W M Abeysekera, Iain Macpherson, Kate Glyn-Owen, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Divalent HIV-1 gp120 Immunogen Exhibits Selective Avidity for Broadly Neutralizing Antibody VRC01 PrecursorsRyan Bailey, Kalista Kahoekapu, Albert To, et al.
Trials|January 17, 2020
CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trialRob Coleman, Janet Brown, Emma Rathbone, et al.
Heart (British Cardiac Society)|December 16, 2023
Cardiovascular sequelae of trastuzumab and anthracycline in long-term survivors of breast cancerClaire Glen, Andrew Morrow, Giles Roditi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 19, 2025
Dysregulation of complement components associated with inflammation and coagulation in virally suppressed people living with HIVNatalie T Subia, Thomas K Awamura, Logan S Dean, et al.
BMC Public Health|January 7, 2023
Laying the foundations for hepatitis C elimination: evaluating the development and contribution of community care pathways to diagnostic effortsEmma Robinson, Christopher J Byrne, James Carberry, et al.
Pageof 3